Avant Technologies Partner, Ainnova, Signs Pilot Program With Roche to Combat Diabetic Retinopathy

Stock Information for Avant Technologies Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avant Technologies Inc

FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market With Vision AI Software
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions
Avant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare Solutions

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.